CAS: 14062-25-0; Ethyl 2-(4-Bromophenyl)Acetate

相似化合物

1878-68-8 4654-39-1 27200-79-9

上下游产品

CAS号64-17-5 乙醇 | CAS号1878-68-8 对溴苯乙酸 | CAS号201230-82-2 carbon monoxide | CAS号106-38-7 对溴甲苯 | CAS号589-87-7 对溴碘苯 | CAS号5764-82-9 乙酸乙酯溴化锌 | CAS号19213-72-0 1-乙氧甲酰咪唑 | CAS号75-03-6 碘乙烷 | CAS号16532-79-9 对溴苯乙腈 | CAS号32454-35-6 2-(4-溴苯基)-2-甲基丙酸 | CAS号5001-94-5 3'-氯-4-联苯乙酸 | CAS号50670-76-3 4'-羟基-4-联苯羧酸乙酯 | CAS号52798-01-3 2-(4-氰基苯基)乙酸甲酯 | CAS号92243-74-8 4-乙氧基羰基甲基苯硼酸 | CAS号183677-02-3 2-(4-溴苯基)噻吩-3-胺 | CAS号105-58-8 碳酸二乙酯 | CAS号28718-78-7 5-溴-2-(4-溴苯基)苯并呋喃 | CAS号27200-79-9 4-溴苯乙醛 | CAS号859169-20-3 (4-乙氧羰基甲苯基)硼酸片钠醇酯

Alpha,4-二溴苯乙酸乙酯置于tert-Butyl N-[(2R)-1,5-Bis(octadecylamino)-1,5-Dioxopentan-2-Yl]Carbamate,Rhodamine 6G,N,N-二异丙基乙胺体系中,用 二甲基亚砜 用作溶剂,化学反应 24.02H,以35%的收率获得对溴苯乙酸乙酯
参考文献:凝胶网络中有氧条件下进行的气敏性光氧化还原催化
标题:凝胶网络中有氧条件下进行的气敏性光氧化还原催化
摘要:在这项工作中,我们证明了可以使用容易制备的凝胶网络作为反应介质,在空气中进行有用的c-c键形成光氧化还原催化,从而获得与在惰性气氛下获得的相似结果.这些反应在空气中的均相溶液中被完全抑制.然而,超分子原纤维凝胶网络限制了反应物并阻止了氧的扩散,从而在环境条件下允许空气敏感的催化活性.我们研究了这种显着保护的机制,着重于自组装超分子凝胶的边界效应,该边界效应在激发态的扩散控制猝灭中提高了生产反应的速率.我们的观察结果表明,在纳米纤维之间的分隔溶剂池内,凝胶网络中发生了三重态敏化化学反应.超分子凝胶介质中粘度的增加和界面的增加似乎是促进有氧条件下反应的关键因素.
Doi:10.1021/acs.Joc.8B00797

专利信息

专利号:US-2022356182-A1
优先权日:2009-03-27
标题 :Inhibitors of hepatitis c virus replication
发明人：COBURN CRAIG A; LUDMERER STEVEN W; LIU KUN; WU HAO; SOLL RICHARD; ZHONG BIN; ZHU JIAN
权利人:MERCK SHARP & DOHME
摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

专利号:US-2024182421-A1
优先权日:2021-03-19
标题 :Synthesis of endochin-like quinolones
发明人：RISCOE MICHAEL K; NILSEN AARON; JIN HAIHONG; POU SOVITJ; WINTER ROLF W; DODEAN ROZALIA ANA; LIEBMAN KATHERINE M
权利人:UNIV OREGON HEALTH & SCIENCE; US GOV VETERANS AFFAIRS
摘要:Described herein are new synthetic routes for production of Endochin-Like Quinolone (ELQ) compounds. Synthetic routes to 3-substituted 4(1H)-quinolones are presented that are amenable to industrial scale preparation. One herein presented approach is relatively short, does not require palladium, and involves no chromatographic separation. A second herein presented approach is similarly relatively short, does not require palladium, involves no chromatographic separation, and also avoids high vacuum distillation. Additionally, both approaches require no protecting group chemistry because the insoluble 4(1H)-quinolone is not formed until the final reaction step.

专利号:US-11053243-B2
优先权日:2009-03-27
标 题:Inhibitors of hepatitis C virus replication
发明人：COBURN CRAIG A; LUDMERER STEVEN W; LIU KUN; WU HAO; SOIL RICHARD; ZHONG BIN; ZHU JIAN
权利人:MERCK SHARP & DOHME
摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

专利号:US-9090661-B2
优先权日:2009-03-27
标 题:Inhibitors of hepatitis C virus replication
发明人：COBURN CRAIG A; MCCAULEY JOHN A; LUDMERER STEVEN W; LIU KUN; VACCA JOSEPH P; WU HAO; HU BIN; SOLL RICHARD; SUN FEI; WANG XINGHAI; YAN MAN; ZHANG CHENGREN; ZHENG MINGWEI; ZHONG BIN; ZHU JIAN
权利人:MERCK SHARP & DOHME
摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

专利号:AU-2018387110-A1
优先权日:2017-12-19
标题 :Synthesis of the 1 :1 :1 co-crystal of 1 -cyano-2-(4-cyclopropyl-benzyl)-4-(beta-D-glucopyranos-1 -yl)-benzene, L-proline and water

专利号:CN-111511725-B
优先权日:2017-12-19
标 题 :1-cyano-2- (4-cyclopropyl-benzyl) -4-) (beta-D-glucopyranos-1-yl) -benzene Synthesis of 1:1:1 Co-crystals of L-proline and Water